REGENXBIO Completes Dosing in Confirmatory Study of RGX-202, Marking Completion of Registrational Development Program and Supporting Planned BLA Submission in Q3 2026
Go back to REGENXBIO Completes Dosing in Confirmatory Study of RGX-202, Marking Completion of Registrational Development Program and Supporting Planned BLA Submission in Q3 2026| Jennison Natural Resources Fund Class B (NASDAQ: RGNX) | Delayed: 8.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.22 | 52 Week High | $25.00 | |||
| Open | $8.22 | 52 Week Low | $7.07 | |||
| Day High | $8.22 | P/E | N/A | |||
| Day Low | $8.22 | EPS | $0.00 | |||
| Volume | 7,202 | |||||
